Revvity, Inc. (PKN.F)
- Previous Close
96.06 - Open
94.42 - Bid 94.68 x 30000
- Ask 95.12 x 30000
- Day's Range
94.42 - 94.60 - 52 Week Range
76.50 - 118.65 - Volume
110 - Avg. Volume
10 - Market Cap (intraday)
11.685B - Beta (5Y Monthly) 1.09
- PE Ratio (TTM)
70.60 - EPS (TTM)
1.34 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield 0.26 (0.27%)
- Ex-Dividend Date Apr 18, 2024
- 1y Target Est
179.17
Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
www.revvity.com11,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PKN.F
Performance Overview: PKN.F
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PKN.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PKN.F
Valuation Measures
Market Cap
11.85B
Enterprise Value
14.15B
Trailing P/E
71.40
Forward P/E
22.08
PEG Ratio (5yr expected)
2.69
Price/Sales (ttm)
4.67
Price/Book (mrq)
1.61
Enterprise Value/Revenue
5.14
Enterprise Value/EBITDA
19.83
Financial Highlights
Profitability and Income Statement
Profit Margin
25.20%
Return on Assets (ttm)
1.72%
Return on Equity (ttm)
2.35%
Revenue (ttm)
2.75B
Net Income Avi to Common (ttm)
179.5M
Diluted EPS (ttm)
1.34
Balance Sheet and Cash Flow
Total Cash (mrq)
1.6B
Total Debt/Equity (mrq)
51.64%
Levered Free Cash Flow (ttm)
1.67B
Research Analysis: PKN.F
Company Insights: PKN.F
PKN.F does not have Company Insights